Literature DB >> 31365326

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31365326      PMCID： PMC6746489          DOI： 10.1080/21645515.2019.1642665

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  4 in total

1.  An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

Authors:  Kevan C Herold; Brian N Bundy; S Alice Long; Jeffrey A Bluestone; Linda A DiMeglio; Matthew J Dufort; Stephen E Gitelman; Peter A Gottlieb; Jeffrey P Krischer; Peter S Linsley; Jennifer B Marks; Wayne Moore; Antoinette Moran; Henry Rodriguez; William E Russell; Desmond Schatz; Jay S Skyler; Eva Tsalikian; Diane K Wherrett; Anette-Gabriele Ziegler; Carla J Greenbaum
Journal:  N Engl J Med       Date:  2019-06-09       Impact factor: 91.245

2.  Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.

Authors:  Mélanie Drolet; Élodie Bénard; Norma Pérez; Marc Brisson
Journal:  Lancet       Date:  2019-06-26       Impact factor: 79.321

3.  Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma.

Authors:  Paolo Antonio Ascierto; Pier Francesco Ferrucci; Antoni Ribas; Rosalie Fisher; Michele Del Vecchio; Victoria Atkinson; Henrik Schmidt; Jacob Schachter; Paola Queirolo; Georgina V Long; Anna Maria Di Giacomo; Inge Marie Svane; Michal Lotem; Gil Bar-Sela; Felix Couture; Bijoyesh Mookerjee; Razi Ghori; Nageatte Ibrahim; Blanca Homet Moreno
Journal:  Nat Med       Date:  2019-06-06       Impact factor: 53.440

4.  A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.

Authors:  Peter T Beernink; Vianca Vianzon; Lisa A Lewis; Gregory R Moe; Dan M Granoff
Journal:  mBio       Date:  2019-06-18       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.